Invention Grant
US08420636B2 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as CCR3 receptor ligands
失效
吡咯烷基 - 烷基 - 酰胺衍生物，它们的制备及其作为CCR3受体配体的治疗应用
- Patent Title: Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as CCR3 receptor ligands
- Patent Title (中): 吡咯烷基 - 烷基 - 酰胺衍生物，它们的制备及其作为CCR3受体配体的治疗应用
-
Application No.: US13014145Application Date: 2011-01-26
-
Publication No.: US08420636B2Publication Date: 2013-04-16
- Inventor: Agnes Behr , Sandor Batori , Veronika Bartane Bodor , Zoltan Szlavik , Imre Bata , Katalin Urban-Szabo , Zoltan Kapui , Endre Mikus
- Applicant: Agnes Behr , Sandor Batori , Veronika Bartane Bodor , Zoltan Szlavik , Imre Bata , Katalin Urban-Szabo , Zoltan Kapui , Endre Mikus
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agent Ronald G. Ort
- Priority: HU0800478 20080731
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D207/08 ; C07D417/14 ; C07D405/12 ; A61K31/4365 ; A61K31/496 ; A61K31/5377 ; A61K31/4025 ; A61K31/40
Abstract:
The present invention relates to pyrrolidinyl-alkyl-amide derivatives of formula (I) or (IA) wherein the variables are as defined herein, to their preparation and to their therapeutic use as CCR3 receptor ligands.
Public/Granted literature
Information query
